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Heritability analyses of resting heart
rate: Is it relevant?
Fariba Ahmadizar1, Maryam Kavousi1 and Pim van der Harst2,3
In this issue of the journal, Xhaard and colleagues1
investigate the heritability of resting heart rate (RHR)
using the data from the STANISLAS family cohort.
This study evaluated RHR heritability in individuals
with a mean age of 33.6 (16.7) years, participating
in four diﬀerent visits, over 20 years of follow-up.
Their results indicated a correlation between parental
and oﬀspring RHR (r2¼ 0.13; P< 0.01), of which
approximately 25% was estimated to originate from
the genetic background and 25% from individuals’
environmental factors (i.e. estimated from repeated
RHR measures). They showed that heritability estima-
tions were sensitive to the time point that might, at least
partly, account for the large heterogeneity (14–39%) of
RHR heritability estimations.
RHR has been recognised as a modiﬁable prognostic
marker of health and disease across many diﬀerent
ancient cultures.2 According to the Greek physician,
Galen (AD 130–200), among the 27 features of the
pulse that can be recognised, RHR was the most
important feature related to individuals’ health. RHR
is commonly considered as an indicator of the balance
between the sympathetic and parasympathetic nervous
system with the antagonistic role from the parasympa-
thetic nervous system in co-regulating heart function.3
The RHR in humans ranges between 60 and 100 beats
per minute (bpm), with substantial variations over the
day altered with diﬀerent situations.44 It is also linked
to individuals’ characteristics in which women are more
likely to have higher RHR compared to men.5
There are several theories on why RHR might be an
important marker, possibly causally, linked to healthy
ageing and the development of disease. In 1997, Levine
presented a hypothesis based on the inverse relationship
between RHR and longevity in mammals, with the
exception of humans, in which large animals such as
elephants with a slow RHR of 15–30 bpm live 20–30
years, while small animals such as mice with a high
RHR of 400–600 bpm live 1–3 years, suggesting
a mean value of 10 108 heart beats per lifetime
(Figure 1).2 This may link to the fact that when the
heart beats faster it has to use more oxygen; it has been
theorised that RHR is an important marker of the basal
metabolism which ultimately determines longevity.6
The ecological observation by Levine supports studies
so far about the impact of RHR on health and disease
development in humans. Recently, Eppinga et al. pre-
sented human data supporting this theory. Using a
Mendelian randomisation approach, including 265,000
individuals from the general population, the authors
also provided evidence for a causal link between RHR
and longevity.7
In many studies, both in healthy individuals as well
as in patients with (cardiovascular) diseases, an
increased RHR is a strong independent predictor of
mortality and morbidity.8 Although the magnitude
of these associations varies across studies, a recent
meta-analysis suggests that every 10 bpm increased
RHR has been associated with a 9% and 8% increased
risk of all-cause mortality and CVD mortality, respect-
ively.9 However, this does not prove causality of RHR
itself, it might be due to confounding factors such as
adrenergic activation aﬀecting both RHR as well as
mortality. However, the most intriguing question may
arise as to whether lowering RHR, for instance from 70
to 60 bpm, has a direct eﬀect on the length of life.
Several animal studies have investigated the eﬀective-
ness of heart rate-lowering drugs; for example, beta-
blockers or selective sinus node inhibitors. These
studies observed that a reduction of RHR by 50%
was associated with an increased life span of  20%.6
Trials of beta-blockers and calcium antagonists also
demonstrated survival beneﬁt closely related to the
reduction in RHR in patients post-myocardial infarc-
tion and heart failure.6 Whether a reduction in RHR
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per se can be translated into long-term clinical beneﬁts
deserves future studies.
Many diﬀerent factors have been identiﬁed that have
an eﬀect on RHR; for example, lifestyle factors, hor-
monal alterations and genetic factors.6 If RHR is
indeed causally linked to health and disease, extensive
knowledge on modiﬁers, including its heritability com-
ponents might be of paramount importance to improve
healthy ageing. A genome-wide association study
(GWAS) on 134,251 individuals has recently reported
the association of 64 genetic variants with RHR, 46 of
these were novel; the amount of variance in RHR
explained by these 64 loci was 2.5% (P< 5 108).7
This suggests that RHR represents a combined eﬀect
from several non-genetic factors. The literature so far
on heritability estimates of RHR among healthy indi-
viduals is highly heterogeneous, with the results ranging
from 14% to 65% in diﬀerent studies. While the het-
erogeneity may be due to the characteristics of the
population studied, it could be explained by diﬀerent
methods, study designs and the residual confounding
eﬀects of non-genetic factors.
Compared to previous ﬁndings from family and twin
studies, the results of the study by Xhaard and col-
leagues showed a lower contribution of genetic factors
(25%) to RHR.1 The lowest heritability estimated by
that study belonged to the subset of children (n¼ 4252,
53%) with a mean (SD) age of 14.3 (3.9) years. Despite
the fact that the results may highlight the contribution
of non-genetic rather than genetic factors inﬂuencing
RHR in the paediatric population, the results might
also be due to the fact that assessing RHR in children
is more challenging.
The study performed by Xhaard and colleagues1 is a
methodologically well designed study in a large popu-
lation (n¼ 10,142), of which 4928 (49%) had GWAS
data. The authors tested RHR heritability from mul-
tiple time point measurements (every 5 years), in four
visits over a 20-year follow-up. Among 4928 individuals
genotyped, 1553 (32%) had more than one RHR meas-
urement during the follow-up and the majority
(n¼ 685) had three measurements. The study used a
linear mixed model at multiple time points. The statis-
tical method simultaneously included both genetic vari-
ants and common environmental eﬀects shared by
families ﬁtted within the ﬁxed eﬀects part. The study
was based on self-reported pedigree or the genetic
relatedness matrix (GRM). The GRM estimates the
genetic relationship between individuals with repeated
measures of RHR. Although the use of GRM calcu-
lated based on GWAS data provides a more accurate
estimation of heritability, the results of both methods
including self-reported pedigree (in all individuals) and
GRM (only in the subset of genotyped individuals)
were very similar. This gives weight to the results of
previous studies on the reliability of self-reported meas-
urements, a simple inexpensive way to measure RHR.10
Several factors should be taken into account when
interpreting the ﬁndings. Notably, a question may
arise as to whether a single RHR measurement reﬂects
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Figure 1. Semilogarithmic relationship between resting heart rate and life expectancy in mammals (amended from Levine, 1997).2
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the heart rate pattern during the whole day and from
day to day. Xhaard and colleagues report on the vari-
ability of RHR, but throughout the paper the termin-
ology of heart rate variability (HRV) is used, which
might be confusing to some readers interested in
changes in time intervals between heart beats and the
inter-beat intervals. HRV analyses and metrics have
been developed to characterise further the autonomic
background of heart rate, and are usually determined
on 24-hour registrations of the electrocardiogram.11
The study did not investigate HRV but rather the vari-
ability of RHR. The study is also limited by investigat-
ing the heritability of HRV for each individual during
follow-up. The HRV measurement, which is a proxy of
healthy cardiac functioning, could help to study the
progression in clinical outcomes as well as to test the
optimal eﬃcacy of interventions. As the study included
participants from diﬀerent visits, an important part of
the variation in RHR, approximately 25%, was attrib-
uted to the repeated measures, which might be due to
changes in methods of RHR measurement over a
20-year follow-up. This may imply that a standardised
procedure of RHR measurement undertaken in clinical
studies would be of importance. Moreover, the analyses
were adjusted for several known risk factors including
age, sex, tea or coﬀee consumption, beta-blocker use,
physical activity, tobacco and alcohol consumption.
However, the possibility still remains that some
unmeasured factors, for instance insulin resistance,
body mass index, stress and hyperlipidemia may have
an impact on RHR indices and could therefore lead to
some residual confounding. In addition, only a small
non-random subset of the cohort had genetic data
available. This subset included the participants who
were older and might have had diﬀerent characteristics,
and could, therefore, aﬀect the study conclusions.
Finally, the study was performed in a highly selected
population. Thus, the results await further conﬁrm-
ation in other cohorts and might not be easily general-
isable to most populations.
Clinical and research implications
There is a continuous interest in RHR and its heritabil-
ity but is it of interest?
Given that RHR is believed to be causally linked to
health and disease, RHR measurement as a simple part
of every clinical examination should be considered.
Driven by new technologies, measuring RHR as one
of the early markers in a wide variety of both cardiac
and non-cardiac disorders becomes applicable for many
individuals, either alone or combined with the other
risk factors. New digital devices; for example, speciﬁc
heart rate apps for mobile phones and watch bracelets
make a reasonably accurate self-measured RHR
possible for the public as well as for clinicians providing
future perspectives of incorporating knowledge of
RHR in personalised preventive strategies.
Assuming there is a genetic causal link, addressing
the full complexity of individuals’ RHR variability,
taking to account gene–environment interaction also
warrants future research. However, given that RHR
heritability is low, it appears that the eﬀect from non-
genetic markers including lifestyle/environmental fac-
tors, physiological and neuropsychological factors is
substantially high. We believe that there is a need to
focus on potential modiﬁable components of RHR in
diverse populations, possibly to help tailor interven-
tions targeting this important cardiovascular disease
risk marker.
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